Public Health at Risk

A US Free Trade Agreement could threaten access to medicines in Thailand

New stringent drug patent and marketing rules being negotiated in a Free Trade Agreement (FTA) between the US and Thailand would limit competition and reduce access to affordable medicines in Thailand. This would threaten the future of existing successful Thai HIV/AIDS treatment programmes, which rely on inexpensive generic drugs, and thus deprive thousands of people of effective treatment. Oxfam opposes an FTA with intellectual property rules that exceed the standards agreed at the World Trade Organization.

This document is available for download (below) in English, French, Thai, Khmer, Vietnamese, and Indonesian translations.



Publication date

Publication type

Briefing paper

Share this publication: Facebook Twitter Instagram YouTube Google+